1 Min Read
July 5 (Reuters) - Cadila Healthcare Ltd
* Says Zydus starts phase II trial of Zyan1 for treating anemia in patients with CKD. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.